Department of Clinical Oncology, Prince of Wales Hospital
Hong Kong, Hong Kong
6 recruiting
Showing 1–9 of 9 trials
Recruiting
Phase 2
JS207 a Bispecific Antibody Against PD1-VEGF in Nasopharyngeal Carcinoma
Recurrent/ Metastatic NPC
Chinese University of Hong Kong49 enrolled1 locationNCT07690787
Recruiting
Not Applicable
SBRT in HCC With Oligoprogression on First-line Immunotherapy
HCC
Chinese University of Hong Kong30 enrolled1 locationNCT06434480
Recruiting
Phase 2
Personalized Antiemetic Regimen According to Patients' Pharmacogenetic Profile
Breast Cancer
Chinese University of Hong Kong200 enrolled1 locationNCT07455955
Recruiting
Not Applicable
Lung Cancer Screening in HIgh Risk nonsmokErs by Artificial inteLligence Device
Lung Cancer
Chinese University of Hong Kong3,000 enrolled1 locationNCT06295497
Recruiting
Impact of Radiotherapy on ctDNA in Patients With Hepatocellular Carcinoma
HCC - Hepatocellular Carcinoma
Chinese University of Hong Kong15 enrolled1 locationNCT06885879
Recruiting
Phase 2
SBRT With Immunotherapy and Atezo-Bev in HCC With Major Portal Vein Thrombosis
HCC
Chinese University of Hong Kong40 enrolled2 locationsNCT06823375
Recruiting
Phase 2
Local Ablative Therapy to Oligoresidual Metastasis in EGFR Mutated Non-small Cell Lung Cancer
Lung Cancer (NSCLC)
Chinese University of Hong Kong64 enrolled1 locationNCT07379476
Recruiting
Phase 2
Neoadjuvant Sacituzumab Govitecan Plus Pembrolizumab in Resectable Non-Small Cell Lung Cancer
Lung Cancer
Chinese University of Hong Kong37 enrolled4 locationsNCT06055465
Recruiting
Phase 2
CXD101 in Immunotherapy-related Liver Cancer
HCC
Stephen Chan Lam44 enrolled2 locationsNCT05873244